Supporting Family Carers' Mental Health

Status Recruiting

Clinical Trial Summary

Brief Summary: Background: Feasibility and acceptability of the Carers-ID intervention to improve mental health outcomes in family carers of people with intellectual disabilities. Objective: 1. To conduct a Phase II feasibility randomised controlled trial and process evaluation of the Carers-ID programme. 2. To determine the acceptability of outcome measures of stress, anxiety, depression, resilience and well-being in assessing the impact of the programme on family carers. 3. To determine the recruitment and retention rates of participants in the trial. 4. To identify potential effect sizes and estimate appropriate sample size for use in an effectiveness trial. 5. To determine if progression to a phase III effectiveness trial is warranted. Methodology: Family carers (n = 120) will be randomised to receive the programme (n=60) or assigned to a wait-list control (n=60) group. The intervention (Carers-ID) consists of ten modules which cover topics including: promoting resilience, reducing anxiety, managing stress, accessing local supports, managing family conflict and information for siblings who are carers. Participants (n=12) who have taken part in the intervention arm of the research will be invited to participate in the process evaluation. Outcome: 1. Retention of Subjects in Study Assessments (>80% of family carers) 2. Recruitment of Subjects into Study (>90 carers) 3. Acceptability and feasibility of the outcome measures (>80% of family carers) 4. Depression, Anxiety and Stress Scale - 21; The Warwick-Edinburgh Mental Well-being Scale; The Resilience Scale; and The Social Connectedness Scale Revised. Number of participants to be enrolled: 120 family carers Main inclusion criteria: Participants will be UK adults >18 years of age and will be caring for a family member with an intellectual disability. Statistical Analysis: Descriptive statistics will be used to summarise baseline data including demographic variables and questionnaire responses. Inferential statistics (t-tests or ANOVA) will be used as indicators of difference between the intervention and control arms and will be used to determine effect sizes for sample size calculation in a future phase III trial. Study duration: 24 months

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Feasibility

Clinical Trial Details

NCT number	NCT05737823
Study type	Interventional
Source	Queen's University, Belfast
Contact	Mark Linden, PhD
Phone	028 9097 2233
Email	m.linden@qub.ac.uk
Status	Recruiting
Phase	N/A
Start date	May 12, 2023
Completion date	March 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05863559` - Super Chef - an Online Program Promoting the Mediterranean Dietary Pattern to Lower Income Families	N/A
Completed	`NCT04169724` - Meditation for Burnout in PA Students	N/A
Active, not recruiting	`NCT04505345` - Virtual Reality Cognitive Training in Alcohol Use Disorder	N/A
Completed	`NCT03286192` - Compassion Cultivation Training for Nurses	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Not yet recruiting	`NCT05790343` - Feasibility Study: Being a Parent - Helping Your Child With Fears and Worries
Terminated	`NCT05503810` - Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness	N/A
Completed	`NCT04150354` - Mental Health Symptom Monitoring Utilizing the Cogito Behavioral Analytic Platform	N/A
Completed	`NCT00557869` - Optimization of Cardiac-MR Protocols	N/A
Active, not recruiting	`NCT06175520` - Introduction of Preconception Care Through Public Health System for Improving MNCH&FP	N/A
Completed	`NCT06371248` - Steady Feet: Preventing Falls in the Community	N/A
Completed	`NCT06063252` - Newly Diagnosed With Inflammatory Arthritis - a Self-management Intervention (NISMA)	N/A
Terminated	`NCT03503968` - TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms	Phase 1/Phase 2
Not yet recruiting	`NCT04305990` - Demand-Driven Method for Gas Delivery in a Dental Setting	N/A
Completed	`NCT04553159` - Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.	Phase 2
Completed	`NCT05697887` - Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam	N/A
Completed	`NCT03237871` - The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults	N/A
Active, not recruiting	`NCT01902238` - EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study	N/A
Completed	`NCT01398059` - The Metabolic Effects of Breaks in Sedentary Time	N/A
Completed	`NCT03556878` - Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.